Literature DB >> 2436906

Use of enzymes for the diagnosis of alcohol-related organ damage.

M Salaspuro.   

Abstract

Elevated levels of serum enzymes are frequently associated not only with alcohol-related organ damage but also with excessive alcohol consumption and alcoholism without significant tissue injury. However, both in the early detection of alcoholism as well as also in the diagnosis of alcohol-related diseases the sensitivities and specificities of these enzyme markers vary considerably. They may be influenced by nonalcohol-related diseases, enzyme-inducing drugs, nutritional factors, metabolic disorders, age, smoking, etc. Consequently, we have neither a single laboratory test--enzyme marker--nor a test combination that is reliable enough for the exact diagnosis between alcohol- and nonalcohol-related organ damage. In most cases it is possible to determine the tissue from which the elevated enzyme is derived, but only occasionally enzyme changes reflect the quantity of the tissue injury. Gamma-glutamyltransferase (GGT) is the most widely used laboratory marker of alcoholism and heavy drinking, detecting 34-85% of problem drinkers and alcoholics. However, the unspecificity of increased serum GGT limits its use for general screening purposes. Its value in the follow-up of various treatment programs, however, is well established. An elevated level of serum aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT) in an alcoholic or a heavy consumer indicates alcohol-induced organ damage. The use of test combinations significantly improves the information received with single serum enzyme determinations. An ASAT/ALAT ratio greater than 1.5 can be considered as highly suggestive for the alcoholic etiology of the liver injury. Still better discrimination between alcoholic and nonalcoholic origin of the liver disease may be achieved by the determination of the ratio of GGT to alkaline phosphatase. If this ratio exceeds 1.4 the specificity of the finding in favor for alcoholic liver injury is 78%. The determination of the mitochondrial isoenzyme of ASAT also improves the diagnostic value of ASAT determination. The ratio of mitochondrial isoenzyme to total over 4 is highly suggestive for alcohol-related liver injury. In general, however, the determination of serum activities of other enzymes such as ornithine carbamyl transferase, lactate dehydrogenase, isocitrate dehydrogenase, sorbitol dehydrogenase, alcohol dehydrogenase, guanase, aldolase, alkaline phosphatase or glutathione S-transferase do not significantly improve the diagnostic information obtained with more conventional laboratory markers of liver injury.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436906     DOI: 10.1159/000469243

Source DB:  PubMed          Journal:  Enzyme        ISSN: 0013-9432


  10 in total

Review 1.  Nonalcoholic fatty liver disease: a clinical review.

Authors:  David A Sass; Parke Chang; Kapil B Chopra
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

Review 2.  The de ritis ratio: the test of time.

Authors:  Mona Botros; Kenneth A Sikaris
Journal:  Clin Biochem Rev       Date:  2013-11

Review 3.  The Importance of Standardization on Analyzing Circulating RNA.

Authors:  Inyoul Lee; David Baxter; Min Young Lee; Kelsey Scherler; Kai Wang
Journal:  Mol Diagn Ther       Date:  2017-06       Impact factor: 4.074

4.  How accurate are blood (or breath) tests for identifying self-reported heavy drinking among people with alcohol dependence?

Authors:  Nicolas Bertholet; Michael R Winter; Debbie M Cheng; Jeffrey H Samet; Richard Saitz
Journal:  Alcohol Alcohol       Date:  2014-04-15       Impact factor: 2.826

5.  Evaluation of coagulation parameters and liver enzymes among alcohol drinkers in Port Harcourt, Nigeria.

Authors:  Teddy Charles Adias; Everton Egerton; Osaro Erhabor
Journal:  Int J Gen Med       Date:  2013-06-14

6.  Chronic consumption of distilled sugarcane spirit induces anxiolytic-like effects in mice.

Authors:  Maria Clecia P Sena; Fabíola C Nunes; Mirian G S Stiebbe Salvadori; Cleyton Charles D Carvalho; Liana Clebia S L Morais; Valdir A Braga
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Comprehensive phenotypic analysis of the Dp1Tyb mouse strain reveals a broad range of Down syndrome-related phenotypes.

Authors:  Eva Lana-Elola; Heather Cater; Sheona Watson-Scales; Simon Greenaway; Jennifer Müller-Winkler; Dorota Gibbins; Mihaela Nemes; Amy Slender; Tertius Hough; Piia Keskivali-Bond; Cheryl L Scudamore; Eleanor Herbert; Gareth T Banks; Helene Mobbs; Tara Canonica; Justin Tosh; Suzanna Noy; Miriam Llorian; Patrick M Nolan; Julian L Griffin; Mark Good; Michelle Simon; Ann-Marie Mallon; Sara Wells; Elizabeth M C Fisher; Victor L J Tybulewicz
Journal:  Dis Model Mech       Date:  2021-10-15       Impact factor: 5.732

8.  Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity.

Authors:  Yunqian Qiao; Yangmin Qiu; Jie Ding; Nana Luo; Hao Wang; Xiaomin Ling; Jiya Sun; Zhihai Wu; Yisen Wang; Yanpeng Liu; Feifei Guo; Ta Sun; Wanwan Shen; Min Zhang; Dongdong Wu; Bingliang Chen; Wei Xu; Xuan Wang
Journal:  Nat Commun       Date:  2021-11-04       Impact factor: 14.919

9.  Rhesus monkey model of liver disease reflecting clinical disease progression and hepatic gene expression analysis.

Authors:  Hong Wang; Tao Tan; Junfeng Wang; Yuyu Niu; Yaping Yan; Xiangyu Guo; Yu Kang; Yanchao Duan; Shaohui Chang; Jianpeng Liao; Chenyang Si; Weizhi Ji; Wei Si
Journal:  Sci Rep       Date:  2015-10-07       Impact factor: 4.379

Review 10.  Biomarker-Based Approaches for Assessing Alcohol Use Disorders.

Authors:  Onni Niemelä
Journal:  Int J Environ Res Public Health       Date:  2016-01-27       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.